FDA approves shoulder expertise from FX Options

FX Options introduced in a press launch that it acquired FDA clearance for its Easytech Stemless Anatomic shoulder prosthesis, meant to deal with painful and disabled shoulder joints.

In response to the discharge, the system is the one stemless shoulder prosthesis with main peripheral fixation available on the market.

“It is a very thrilling addition to our complete portfolio and can enable us to compete within the stemless market with an incredible prosthesis that, with its main peripheral fixation, ought to give us a aggressive benefit and probably enhance affected person outcomes with a bone sparing system,” Baptiste Martin, CEO of FX Shoulder, stated within the launch.

In response to the discharge, the Easytech Anchor base permits the system to suit contained in the cortical bone, the place bone high quality is perfect for fixation.

“Since its launch in Europe, the Easytech Stemless Anatomic has change into the first alternative of surgeons for his or her anatomic whole shoulder replacements with demonstrated glorious medical success,” in keeping with the discharge.